D. Sedláček

发表

Chronic Kidney Disease and Exposure to ART in a large cohort with Long-term Follow-up: The EuroSIDA study

A. Mocroft, O. Kirk, J. Gatell, 2010 .

Can serological methods be helpful in the diagnosis of COVID-19 in cases of repeated false negative results of PCR tests?

Robin Šín, D. Sedláček, Miroslav Kubiska, 2020, Medicína pro praxi.

HIV care in Central and Eastern Europe: How close are we to the target?

M. Poljak, A. Horban, K. Rüütel, 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.

C. Leen, A. Mocroft, M. Laguno, 2020, AIDS.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

A. Mocroft, O. Kirk, J. Lundgren, 2018, AIDS.

Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

C. Leen, A. Mocroft, R. Weber, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Observational cohort study of rilpivirine (RPV) utilization in Europe

C. Leen, A. Mocroft, R. Paredes, 2022, AIDS Research and Therapy.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Long-Term Monitoring of the Antibody Response to a SARS-CoV-2 Infection

R. Kučera, O. Topolcan, Robin Šín, 2021, Diagnostics.

The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group

A. Horban, I. Karpov, R. Matulionytė, 2022, Viruses.

A comparison of the long‐term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

A. Mocroft, J. Lundgren, C. Katlama, 2011, HIV medicine.

Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection

P. Panzner, M. Terl, D. Sedláček, 2020 .

The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe

J. Lazarus, P. Schmid, M. van der Valk, 2022, AIDS.

Seven Antiphospholipid Antibodies in HIV‐Positive Patients: Correlation with Clinical Course and Laboratory Findings

P. Nováková, D. Sedláček, Z. Ulčová-Gallová, 2003, American journal of reproductive immunology.

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

A. Mocroft, O. Kirk, J. Gatell, 2010, AIDS.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Liver abscess in human toxocariasis.

J. Ferda, V. Treska, H. Mírka, 2011, Bratislava Medical Journal.

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test

R. Kučera, O. Topolcan, T. Fürst, 2021, Diagnostics.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe – data from Euro-guidelines in Central and Eastern Europe Network

A. Horban, I. Karpov, J. Begovac, 2019, Infectious diseases.

Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) Trial

H. Furrer, J. Lundgren, J. Boatman, 2019, Journal of acquired immune deficiency syndromes.

Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm 3 : Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial

H. Furrer, J. Lundgren, J. Boatman, 2022 .

Exposure to dolutegravir in pregnant women living with HIV in Central and Eastern Europe and neighboring countries - data from the ECEE Network Group.

J. Kowalska, E. Siwak, D. Sedláček, 2019, Ginekologia polska.

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

C. Katlama, D. Cooper, B. Grund, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Prevalence of human leukocyte antigen HLA-B*57:01 in HIV-infected subjects in the Czech Republic.

M. Malý, S. Snopková, D. Sedláček, 2011, Central European journal of public health.

Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

A. Horban, J. Tomažič, R. Matulionytė, 2020, HIV medicine.

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future

J. Tomažič, R. Matulionytė, I. Alexiev, 2023, Vaccines.

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death

R. Paredes, B. Clotet, A. Phillips, 2014, PloS one.

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

A. Mocroft, J. Gatell, P. Reiss, 2017, AIDS.

Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death

R. Paredes, B. Clotet, A. Phillips, 2014, Journal of the International AIDS Society.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.

Histamine increases the level of IFNγ produced by HIV-1 specific CTLs and this production depends on total IgE level.

P. Panzner, M. Malý, D. Sedláček, 2012, Journal of immunological methods.

Patient living with HIV in a general practitioner's outpatient clinic

D. Sedláček, S. Hofman, 2022, Medicína pro praxi.

Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.

R. Paredes, H. Furrer, A. Phillips, 2023, NEJM evidence.

Increased risk of suicidal behaviour with use of efavirenz: results from the START trial

C. Katlama, D. Cooper, B. Grund, 2016 .

Measles as a real nowadays threat

D. Sedláček, Lenka Kukrálová, Mirka Švecová, 2019, Pediatrie pro praxi.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.